LNP 1955

Drug Profile

LNP 1955

Alternative Names: LND 400111; LNP-1955; SUB177091

Latest Information Update: 07 Nov 2017

Price : *
* Final gross price and currency may vary according to local VAT and billing address.

At a glance

  • Originator Lupin
  • Class Anti-inflammatories; Antipsoriatics; Antirheumatics
  • Mechanism of Action Immunomodulators
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

  • New Molecular Entity Yes

Highest Development Phases

  • Phase II Plaque psoriasis; Rheumatoid arthritis

Most Recent Events

  • 11 Oct 2017 Lupin completes a phase II trial in Plaque psoriasis in Hungary (PO) (EudraCT2016-001531-12)
  • 16 Aug 2016 Phase-II clinical trials in Plaque psoriasis in Hungary (PO) (EudraCT2016-001531-12)
  • 08 Aug 2016 Phase-II clinical trials in Rheumatoid arthritis in Hungary (PO) (EudraCT2016-001532-35)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top